Piper Sandler began coverage on shares of Enfusion (NYSE:ENFN – Get Rating) in a research report report published on Monday, The Fly reports. The brokerage issued a neutral rating and a $11.00 price target on the stock. The analysts noted that the move was a valuation call. A number of other research firms also recently […]
Piper Sandler initiated coverage on shares of Enfusion (NYSE:ENFN – Get Rating) in a research note issued to investors on Monday morning, The Fly reports. The brokerage issued a neutral rating and a $11.00 price objective on the stock. The analysts noted that the move was a valuation call. A number of other research firms […]
Enfusion, Inc. (NYSE:ENFN – Get Rating) CTO Dan Groman sold 3,877 shares of the business’s stock in a transaction dated Friday, March 17th. The shares were sold at an average price of $10.94, for a total value of $42,414.38. Following the sale, the chief technology officer now directly owns 85,979 shares of the company’s stock, […]
Enfusion (NYSE:ENFN – Get Rating) is one of 419 publicly-traded companies in the “Prepackaged software” industry, but how does it compare to its rivals? We will compare Enfusion to similar companies based on the strength of its dividends, risk, earnings, institutional ownership, valuation, analyst recommendations and profitability. Profitability This table compares Enfusion and its rivals’ […]